In a letter to the FDA, he also urged the agency to adopt successful approaches from other countries and consider private-public partnerships.
Earlier this week, the FDA announced a “Strategic Plan for Regulatory Science” initiative to foster innovation through better science.
Related Articles on FDA Medical Device Regulatory Reform:
New England Journal Agrees FDA Device Process Must be Overhauled
FDA Clarifies Device Approval Process
FDA Proposes Updating Device Reviews, Including for Joints, IOLs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.